4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Lipid Lowering Therapy
Lipid Lowering Therapy, a crucial component in cardiovascular health, focuses on managing and reducing elevated levels of cholesterol and triglycerides in the bloodstream. This therapeutic approach plays a pivotal role in preventing and mitigating cardiovascular diseases, such as heart attacks and strokes. Often involving medications known as statins, fibrates, or cholesterol absorption inhibitors, Lipid Lowering Therapy aims to regulate lipid levels and promote overall cardiovascular well-being. Alongside lifestyle modifications such as a heart-healthy diet and regular exercise, this therapeutic strategy is instrumental in addressing one of the primary risk factors for cardiovascular complications. Regular monitoring and personalized treatment plans contribute to the effectiveness of Lipid Lowering Therapy, underscoring its significance in the comprehensive management of cardiovascular health.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado , Chile